// App-Quantinova.ai

DMT22 : Development and Interrelation of Whole-Brain Atrophy and Lesion Volume in Patients with a First Clinical Demyelinating Event in the REFLEX/ION Study

Researchers

Presenter

  • Rozemarijn Mattiesing

Principal Investigators

  • Giordano Gentile

  • Iman Brouwer

  • Dominic Jack

  • Frederik Barkhof

  • Nicola De Stefano

  • Bernard MJ Uitdehaag

  • Jos WR Twisk

  • Marco Battaglini

  • Hugo Vrenken

Medical Centers

  • Department of Neurology, MS Center Amsterdam, Amsterdam, Netherlands

  • Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy

  • SIENA imaging SRL, Siena, Italy

  • UCL Institutes of Neurology and Healthcare Engineering, London, United Kingdom

Locations

  • Netherlands

  • United Kingdom

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Interferon beta-1a

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A